Melanoma Institute Australia

MRFF EMCR Initiative - Early to Mid-Career Researchers Grant
2026-08-19 17:00 (Australia/Sydney)
The Medical Research Future Fund (MRFF) –2026 Early to Mid-Career Researchers Grant Opportunity will support research to build and grow research capacity and capability in Australia by supporting Early to Mid-Career Researchers (EMCRs) to continue their health and medical research careers.
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Incubator): conduct early stage, small scale research, led by early career researchers, that seeks to assess the potential and feasibility of novel strategies to address a critical or intractable health issue in one or more Priority Populations.
Stream 2 (Accelerator): establish a large-scale interdisciplinary research program, led by mid-career researchers, that drives implementation of substantial improvements to health care and/or health system effectiveness for one or more Priority Populations.
Stream 3 (Targeted Call for Research): utilise co-funding to accelerate the translation of research led by early or mid-career researchers into policy and practice. (Note: a priority population focus is not required).

The intended outcome of the research is to improve the health and wellbeing of Australians by:

Stream 1 (Incubator): supporting early career researchers to develop innovative solutions for addressing significant health challenges in Priority Populations.
Stream 2 (Accelerator): supporting mid-career researchers to transform health practice and/or policy for Priority Populations.
Stream 3 (Targeted Call for Research): supporting early to mid-career researchers to translate new health solutions into practice.

Key Dates:
Minimum data due: 22 July 2026
Applications close: 19 August 2026
Grant activity timeframe: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF Genomics Health Futures
2026-08-19 17:00
The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:
Stream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy.
Stream 2 (TCR): conduct scalable research to enhance novel gene discoveries, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies.
Stream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease, diabetes and other common and/or complex diseases).
Stream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer, colorectal cancer, prostate cancer and other common cancers)
Stream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice.
Stream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing, portability, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics.
Applicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan.
Key Dates

Minimum data due date: 22 July 2026
Applications close: 19 August 2026
Indicative funding status: Funding anticipated to be awarded from June 2027
SEE GRANT GUIDELINESSEE WEBSITE

MRFF Preventive and Public Health Research Initiative - 2026 Consumer-Led Research Grant
2026-08-05 17:00
The Medical Research Future Fund (MRFF) – 2026 Consumer-Led Research Grant Opportunity will support research that:

Stream 1 (Incubator): identify health priorities, develop new approaches and/or methodologies and conduct pilot studies addressing health issues and/or barriers that:

are co-led, co-produced and/or co-designed with consumers
are in partnership with health services
increase consumers’ understanding of, and involvement in, research.

Stream 2 (Targeted Call for Research): develop and/or test scalable and sustainable approaches, in partnership with consumers, that enable self-care interventions or improve quality of life and/or survivorship care. Approaches are for individuals from one or more priority populations, who have experienced or are experiencing long term diseases and conditions. Approaches may, where appropriate, also deliver for the individual’s families, carers and communities.
Topic A: Research projects that focus on cancer
Topic B: Research projects that focus on long term physical diseases and conditions other than cancer
Topic C: Research projects that focus on mental health challenges, diseases or conditions.

The anticipated outcome of the research is to improve the health and wellbeing of Australians by:

Stream 1 (Incubator): developing effective approaches for addressing health priorities for communities and that build capability for consumer involvement in research
Stream 2 (Targeted Call for Research): developing effective approaches to improve the health and/or wellbeing for those who have experienced or are experiencing long term diseases and conditions

Key Dates:
Minimum data due: 8 July 2026
Applications close: 5 August 2026
SEE GRANT GUIDELINESSEE WEBSITE

MOGA Annual Scientific Meeting
2026-08-05 - 2026-08-07 | RACV Royal Pines Resort, Ross Street, Gold Coast, Queensland, 4217, Australia
The 2026 MOGA Annual Scientific Meeting (ASM) will bring together Australian medical oncologists to reflect on a timely theme:
Reimagining Cancer Care: Is Less Doing More?
In recent years, oncology has found itself at a fascinating crossroads. With ever-deepening insights into tumour biology, immunotherapy, molecular profiling, and patient-centred care, we are beginning to ask a powerful and, at times, uncomfortable question: Are we sometimes doing too much?
We are now confronting the possibility that treatment de-escalation is not just a compromise, but potentially a pathway to more humane, precise, and effective care. This conversation extends well beyond protocols and guidelines. It challenges us to think deeply about patient autonomy, shared decision-making, and what quality of life truly means in the era of personalised medicine.
This ASM will bridge disciplines and perspectives—from surgical oncology to medical and radiation oncology, to palliative care and psychosocial support. We will consider not only clinical evidence, but also the ethical, logistical, and emotional dimensions of doing less. We will look at emerging biomarkers and novel drug targets that allow us to fine-tune therapy like never before. Exploring what it means to personalise care in the truest sense—not just through science, but through listening.
Location: RACV Royal Pines, Gold Coast, Australia
Key Dates:
Early Bird Registrations Close: 14 June 2026
Abstract Submissions Close: 14 June 2026
Abstract Selection Advice: 3 July 2026
Abstract Acceptance by Presenter: 10 July 2026
Travel Award Applications Open: 3 July 2026
Travel Award Applications Close: 10 July 2026
Travel Award Recipient Notification: 17 July 2026
FIND OUT MORE

RACP Research Awards and Career Grants
2026-07-31 17:00
Through the RACP Foundation, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships, scholarships and grants are available annually, totalling over $2.5 million in funding.
Career Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships.
Research Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career.
Research Entry Scholarships provide up to $45,000 stipend support to Advanced Trainees and Fellows who are at the start of their research careers, helping them undertake a Masters, PhD or equivalent higher degree and build a foundation for a future in medical research.
Research Development Grants provide from $10,000 to $30,000 in funding for smaller research projects for beginning researchers. Applicants can undertake a short-term or part-time research project.
Travel Grants provide from $10,000 to $30,000 funding to support RACP trainees and Fellows undertaking short periods of research, study or international collaboration.

Key Dates
Applications close:
Career Development & Research Establishment Fellowships: 30 June 2026
Research Entry Scholarships: 7 July 2026
Research Development Grants: 24 July 2026
Travel Grants: 31 July 2026
Outcomes advised: December 2026
SEE WEBSITE

The RACP Trainee Research Awards Symposium
2026-07-31 | RACP, 145 Macquarie Street, Sydney, NSW, Australia
Join us in celebrating the next generation of physician researchers at the RACP Trainee Research Awards Symposium.
Hear outstanding trainees from across Australia and Aotearoa New Zealand present their innovative research in paediatric and adult medicine. We’ll be joined by our guest speaker, renal and transplant physician, Associate Professor Melanie Wyld, alongside members of the College Research Grants Committee.
All members are welcome. The Symposium will be of particular interest to trainees who are considering, starting or continuing a career in medical research.
Location: RACP Office, 145 Macquarie Street, Sydney / Online

Key Date: Friday, 31 July 2026 from 2.30pm to 6pm AEST
FIND OUT MORE

NHMRC Investigator Grants
2026-07-29 17:00
Investigator Grants provide the highest-performing researchers at all career stages with consolidated funding for their salary (if required) and a significant research support package.
In this way, the Chief Investigator has flexibility to pursue important new research directions as they arise, adjust their resources accordingly, and to form collaborations as needed, rather than being restricted to the scope of a specific research project.
Investigator Grants support:

Research across the 4 pillars of health and medical research: biomedical, clinical, public health and health services research.
All career stages: early career researchers, mid-career researchers and established researchers
Researchers with clinical responsibilities (such as clinicians, public health and allied health practitioners)
Full-time and part-time researchers.

Investigator Grants aim to:

Allow flexibility for investigators to pursue important new research directions as they arise and to form collaborations as needed
Foster innovative and creative research
Create opportunities for researchers at all career stages to establish their own research programs
Reduce application and peer review burden on researchers.

Key Dates:
Applications open: 3 June 2026
Minimum data due: 1 July 2026
Applications close: 29 July 2026
Proposed peer review: August – November 2026
Outcomes to be advised: March 2027
SEE GRANT GUIDELINESSEE WEBSITE

SHP Annual Forum
2026-07-29 | Kerry Packer Education Centre, John Hopkins Drive, Camperdown, NSW, 2050, Australia
As an NHMRC-accredited Research Translation Centre, Sydney Health Partners leverages the collective strength of our partners to accelerate the adoption of evidence into practice. This year’s Forum explores how we can work together to build lasting impact through effective research translation, strengthen clinician‑to‑researcher career pathways, and ensure our research remains globally competitive and in alignment with the priorities of our healthcare system.
Reflecting on another successful year of research translation, the Forum will also celebrate excellence through our annual awards, and shine a light on the essential role of genuine consumer–researcher partnerships in shaping research that truly matters.
Keynote speakers:

Adjunct Professor Michael Nicholl, Chief Executive, Clinical Excellence Commission
Professor John Prins, Dean, Faculty of Medicine and Health, University of Sydney

Location: Kerry Packer Education Centre, Johns Hopkins Drive (Off Missenden Road), RPA Hospital Precinct, Camperdown NSW
Key Date: 1:00-5:00 pm, Wednesday 29 July 2026 (followed by networking refreshments)
FIND OUT MORE

Plastic Surgery Congress 2026
2026-07-24 - 2026-07-25 | Sofitel Brisbane Central, 249 Turbot Street, Brisbane, QLD, 4000, Australia
Australian Society of Plastic Surgeons welcomes you to the 2026 Plastic Surgery Congress (PSC), where the future of plastic, reconstructive, and aesthetic surgery takes centre stage.
​Taking place at the Sofitel Brisbane Central, PSC 2026 promises a dynamic program packed with cutting-edge content, world-class presentations, and the latest global best practices. With two full days of medical education, hands-on workshops, and lively social events, the Congress is designed to spark collaboration and professional growth.
​In 2026, delegates can expect an exceptional line-up of international and local faculty, carefully curated to provide a truly bespoke educational experience. We have introduced a refreshed academic focus, featuring topics not previously explored in depth at past congresses. These include burns, peroneal reconstruction, hands and brachial plexus surgery, and aesthetics. And of course, no congress held in Brisbane would be complete without a dedicated emphasis on skin cancer.
​Expect an exceptional line-up of international and local experts who will showcase ground-breaking techniques and transformative ideas shaping the field today.
​Key Dates
Abstracts close: 9 February 2026
Early bird registration closes: 22 April 2026
Congress Venue
Sofitel Brisbane Central
249 Turbot Street Brisbane QLD 4000 AUSTRALIA​
​
FIND OUT MORE

ASDR Annual Scientific Meeting
2026-07-23 - 2026-07-25 | Westmead Innovation Centre, Hawkesbury Rd, Sydney, NSW, 2145, Australia
The Australasian Society for Dermatology Research (ASDR) is pleased to invite you to the ASDR 2026 Annual Scientific Meeting, to be held in person from 23–25 July 2026 at the Westmead Innovation Centre, Sydney, Australia. The meeting will deliver a comprehensive scientific program featuring leading national and international experts, highlighting recent progress and emerging directions in dermatology research. Key areas to be explored include:

Keratinocyte and Squamous Cell Carcinomas
Melanocyte/ Keratinocyte biology
Microenvironment
Fundamental Skin Research
Skin immunology and immune disorders
Autoimmune Disorders
Wound Healing and Stem Cells
Melanoma and Pigmentation Disorders
Skin Translational Research

We look forward to bringing together researchers, clinicians, and industry leaders to foster collaboration and discussion on the most innovative topics in dermatology research.
Location: Westmead Innovation Centre, Sydney, Australia
Key Dates:
Abstract Submission Deadline: 19 April 2026
Abstract Outcomes: 15 May 2026
Early Bird Registration Deadline: 30 June 2026 at 23:59 AEST
Registration Deadline: 16 July 2026 at 23:59 AEST
FIND OUT MORE

MRFF BioMedTech Incubator
2026-07-22 17:00
The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators.
This grant is for an eligible organisation who can establish a working incubator, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development.
The 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative.
This opportunity looks to fund suitable organisations to identify, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential.
The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers, diagnostics, therapeutics, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation.
Applicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector).
Grants of up to $33 million to establish BioMedTech Incubators.

Key Dates
Applications close: 22 July 2026
Indicative funding status: Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

MRFF National Critical Research Infrastructure
2026-07-14 17:00
The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams.
Stream 1 – Innovation enablers
Address an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks, tissue repositories, novel platforms, and secure health data environments to create valuable research resources.
Stream 2 – Digitisation of health care
Translate or implement innovative artificial intelligence technologies into health applications that:

benefit multiple health disciplines/areas
involve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and
increase artificial intelligence workforce capacity and capability, particularly in relation to health, through cross-sector and interdisciplinary collaboration.

Stream 3 – Co-investment partnerships
Utilise co-investment (cash only) with the research sector, state and/or territory governments, and industry, in significant critical research infrastructure (e.g. facilities, personnel and equipment):

to support development of research capacity, capability and/or effectiveness in an area of unmet medical need, or
to enable Australian research using new platforms, systems and services in an area of unmet medical need.

Stream 4 – mRNA technology enablers
Leverage and enhance emerging mRNA technologies, platforms, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need.
Grants to fund research infrastructure projects, up to $3 million in Streams 1, 2 and 4, and up to $7 million in Stream 3.
An application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application.

Key Dates
Applications close: 14 July 2026
Indicative funding status: Funding anticipated to be awarded from December 2026
SEE GRANT GUIDELINESSEE WEBSITE

MPA-MIA Community Webinar Series 2026
2026-07-14 - 2026-07-28
Join us for an informative series of three live webinars for patients with melanoma and their carers.
Hosted by Melanoma Patients Australia (MPA) and Melanoma Institute Australia (MIA), each week our free webinar will provide you with a rare opportunity to hear from medical experts and community members as they focus on a different topic of interest each week. The webinar will conclude with a Q&A panel discussion.
The webinars are held every Tuesday evening for three weeks. Please click on the registration link below for each webinar that you’d like to attend.
Note that the webinars are held from 7pm to 8pm AEST.
Cost: Free
Webinar One: ‘Your melanoma nurse: What they do and how they help’
Held on Tuesday 14 July
Speakers:

Peta Holly, Specialist Melanoma Telehealth Nurse
Rebecca Johnson, National Melanoma Nurses Program Manager
Ted Mlynarz, Patient Speaker

WATCH RECORDINGWebinar Two: ‘Understanding endocrine side effects of immunotherapy’
Held on Tuesday 21 July
Speakers:

Dr Stephanie Zunder – Medical Oncologist
Dr Annabelle Hayes – Endocrinologist
Aled Gaynor – Medical Oncology Clinical Nurse Consultant
Carmel Finnegan – Community member

WATCH RECORDINGWebinar Three: ‘Understanding sentinel lymph node biopsies: Helping you decide’
Held on Tuesday 28 July
Speakers:

A/Prof Alexander van Akkooi – Surgical Oncologist
Shahn Coburn – Nurse Practitioner
Ella Ania – Community member

WATCH RECORDING

NSW Premier's Awards for Outstanding Cancer Research
2026-07-13 12:00
The Cancer Institute NSW is delighted to announce the return of the NSW Premier’s Awards for Outstanding Cancer Research, a prestigious event that pays tribute to the remarkable accomplishments of individuals and teams within the cancer research community and those supporting innovation and cutting-edge delivery of care.
Now is your chance to nominate an exceptional team or individual. The Outstanding Cancer Clinical Trials Unit Award is especially relevant to your work.
This Award recognises a high-performing cancer clinical trials unit in New South Wales that demonstrates operational excellence, leadership in trial conduct, and commitment to advancing access to cancer clinical trials.
Nominations are now open across nine award categories:
• Outstanding Cancer Researcher of the Year Award
• Outstanding Early Career Researcher Award
• Outstanding Mid-Career Researcher Award
• Rising Star PhD Candidate Award
• Outstanding Cancer Clinical Trials Unit Award
• Consumer Engagement in Cancer Research Award
• Cancer Control Innovation Award
• Improving Equitable Outcomes through Cancer Research Award
• Reducing Cancer Inequality for Aboriginal People Award
These categories highlight progress and success in line with the strategic goals of the NSW Cancer Plan and NSW Aboriginal Cancer Strategy.
The winners will be announced at the NSW Premier’s Awards for Outstanding Cancer Research event to be held at 5.00pm Thursday 19 November 2026 at NSW Parliament House.
Anyone involved in improving cancer patient outcomes within NSW is eligible to be nominated.
Key date:
Nominations close 12pm (noon) Monday 13 July 2026.
SEE GRANT GUIDELINESSEE WEBSITE

SHP Pilot Grants
2026-07-03 17:00
SHP Pilot Grants – Funding to Test and Implement Research Into Clinical Practice
Each year, Sydney Health Partners funds pilot projects that help clinicians, researchers and health professionals turn evidence into practical healthcare solutions and scale up the implementation of research for broader impact.
If you’re a health professional, clinician, or researcher leading research within Sydney Health Partners’ affiliated health services, a Pilot Grant could help you to:

Test real-world implementation of research innovations
Solve complex health system challenges with practical solutions
Strengthen applications for major funding bodies (NHMRC, MRFF, TRGS)

Applications are now open for Sydney Health Partners 2026 Implementation Science Pilot Grants.
Sydney Health Partners are offering up to $220,000 in grants to support up to 11 pilot projects, with two of the projects to be funded by the Charles Perkins Centre Implementation Hub through the Jennie Mackenzie Research Fund.
Grant Categories:
Stream 1: SHP Implementation Science Pilot Grants (up to 9)
These grants require two Principal Investigators (PIs):

One from the University of Sydney or an SHP Partner Medical Research Institute (MRI)

One from an SHP Health Service Partner

Stream 2: CPC Implementation Hub Pilot Grants (x2)
These grants require two PIs – One must be a member of the Charles Perkins Centre:

One must be a University of Sydney or SHP Partner MRI employee

One from an SHP Health Service Partner

Key Dates:
Applications close: 3 July 2026, 5:00pm AEST
Successful applicants will be notified: August 2026
Grants will commence: from January 2027
SEE GRANT GUIDELINESSEE WEBSITE

ASCO Breakthrough
2026-06-25 - 2026-06-27 | Raffles City Convention Centre, 80 Bras Basah Road, Singapore, 189560, Singapore
ASCO Breakthrough is an annual Asia-Pacific oncology meeting offering novel research and expert, multidisciplinary perspectives on the newest scientific findings, clinical and technology advances, and treatment approaches that are rapidly changing cancer care. Take part in insightful sessions, case discussions, and abstract presentations, and join a community of like-minded professionals to contribute, together, toward conquering cancer.
Why Attend ASCO Breakthrough?

Access Global Science with Regional Perspectives
Connect with the Global ASCO Community in Asia
Gain Insight to Enhance Your Clinical Practice

Program Overview
Sessions will cover a range of topics, including:

Confronting the Global Surge of Early-Onset Cancers
A Discussion on What It Will Take to Make Clinical Artificial Intelligence a Reality at the Bedside
Antibody-Drug Conjugates
New Immunotherapy Combination Strategies
Minimal Residual Disease in 2026 and What Is On The Horizon
Advancing Equitable Oncology in the Asia-Pacific Region – Bridging Gaps With Common Sense
Case-Based Sessions focused on Liver Cancer, Cervical Cancer, and Oral Cavity Cancers

The Program will also include scientific update sessions, the presentations of new and novel scientific advances, and opportunities for attendees to network and connect with each other to build meaningful partnerships.
Location: Raffles City Convention Centre, Singapore
Key Dates:
Conference dates: 25 – 27 June, 2026
Early registration deadline: 20 May, 2026 at 11:59 PM (ET)
FIND OUT MORE

Hervey Bay Half Marathon Festival 2026
2026-06-21
The Hervey Bay Half Marathon Festival offers runners a truly unique coastal experience, set against the stunning backdrop of Queensland’s Fraser Coast. With sweeping ocean views, tranquil beaches, and an inviting esplanade lined with palms and cafés, participants will be immersed in the laid-back charm and natural beauty of this coastal paradise.
Whether you’re chasing a personal best or simply soaking up the scenery, the course makes the perfect setting for all types of runners—from seasoned athletes to first-timers.
With a variety of distances on offer — Half Marathon – 21.1km | 10km | 5km run & 5km walk | 2km Fun Run & Walk — there’s something for everyone to experience the excitement of crossing the finish line along Hervey Bay’s iconic foreshore.
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

2026 New Zealand Skin Cancer Summit
2026-06-18 - 2026-06-20 | InterContinental Wellington, 2 Grey Street, Wellington, 6011, New Zealand
The Summit Organising Committee invites you to join the 2026 New Zealand Skin Cancer Summit. This year marks a new chapter — the first Summit under the new name, Skin Cancer New Zealand, and the first to address all types of skin cancer, not just melanoma.
Our 2026 theme, “Equity in action: Bridging gaps for skin cancer”, reflects our commitment to ensuring prevention, early detection, treatment, and support are accessible and equitable for everyone. The programme will feature engaging keynote presentations, interactive panels and skills-based workshops showcasing innovative research, practical strategies, and collaborative approaches.
Bringing together clinicians, researchers, educators, policymakers, and advocates from across New Zealand and beyond, the Summit offers a unique opportunity to share knowledge, strengthen networks, and set priorities for skin cancer management that will help to reduce the burden of disease and improve outcomes for those affected.
Optional pre-Summit workshops | 18 June 2026
9.00 am – 12.30 pm: Skin Surgery Masterclass
1.30 pm – 4.30 pm: Advanced Dermoscopy Masterclass
These workshops can be booked individually or together with the Summit. Summit registration is not required to sign up for one or both workshops.
New Zealand Skin Cancer Summit | 19 – 20 June 2026
With the theme of bridging gaps in skin cancer, the Summit will aim to shape a coordinated and equitable future for skin cancer care, foster collaboration, and share the latest advancements in prevention, diagnosis, treatment and research. A dynamic programme packed with internationally recognised experts and sessions on prevention, diagnosis, clinical management, and research, makes this an event not to be missed.
Location: InterContinental Wellington, Wellington, NZ
Key Dates:
Early bird registration closes: 31 March 2026
Abstract Submission deadline: 27 March 2026
Abstract Outcomes: 17 April 2026
E-poster Submission deadline: 23 May 2026
FIND OUT MORE

SHP Annual Awards
2026-06-17 17:00
Sydney Health Partners Awards celebrate outstanding early career researchers, clinician researchers, and consumers who are creating lasting impact in clinical and health services research. Award winners will be announced at the upcoming SHP Annual Forum on 29 July 2026.

Award Categories

Early career researchers and clinician researchers can apply or be nominated for one of five Awards:

Translational Research Addressing a Health Priority
Clinical Trial Excellence
Excellence in Consumer-Researcher Partnerships
Researcher–Health Professional Collaborations
SHP Using Research to Change Health Practice

Each Award winner will receive funding of $2,000 for:

research-related professional development expenses, and/or
payments for consumers partnering in research.

Nominees for the early career researchers and clinician researcher awards must be employed by a Sydney Health Partner organisation.

Consumer Contributions to Health Research

This consumer-focused award recognises the valued contribution of consumers who are actively involved in shaping health research that matters. Consumers can either self-nominate or be nominated by others.
The Consumer Award includes a gift card to the value of $250.
All nominations must include endorsement from a senior manager or researcher employed by a Sydney Health Partner organisation.

Nominate Now:

Nominations for the 2026 SHP Awards are now open and will close at 5:00pm AEST on Wednesday, 17th June 2026.

SEE GRANT GUIDELINESSEE WEBSITE

CNSA Annual Congress
2026-06-17 - 2026-06-19 | Perth Convention and Exhibition Centre, 21 Mounts Bay Rd, Perth, WA, 6000, Australia
The Cancer Nurses Society of Australia (CNSA) Annual Congress is the premier national event for cancer nurses, researchers, educators, and leaders in cancer care. Each year, Congress brings together professionals from across Australia to connect, share, and advance cancer nursing practice.
Over three days, delegates experience keynote presentations, interactive workshops, concurrent sessions, poster displays, and networking events designed to inform, inspire, and empower. Congress provides a platform to exchange ideas, explore evidence-based innovations, and shape the future of cancer care through nursing leadership and advocacy.
In 2026, under the theme Elevate Cancer Nursing: Innovate. Integrate. Educate. Advocate., we’ll highlight how nurses are driving change — translating evidence into practice, leading multidisciplinary collaboration, and championing equity in cancer care.
Location: Perth Convention and Exhibition Centre, Australia
Key Dates: 17 – 19 June 2026
FIND OUT MORE

NSW Health Medical Devices Fund
2026-06-09 17:00
The Medical Devices Fund provides grants to drive the commercialisation of highly innovative new devices and technologies in NSW, addressing gaps in the product life cycle between early-stage research and mature investment opportunities.

The Medical Devices Fund aims to:

Support individuals, companies, public and private hospitals, medical research institutes, universities, other public sector research organisations, and the medical devices industry, to take local innovation to market

Increase the uptake of NSW medical devices that are cost effective and contribute to improved patient outcomes.

For Round 14, applicants with projects that address the following NSW Health Research and Innovation Strategy aligned priorities are encouraged to apply:

Women’s Health
Female Entrepreneurs
Aboriginal Health

Applicants with projects that do not address the above priorities are also able to apply.

The program funds project activities used for any purpose that meets the objectives of the program, subject to the exclusions below.
Examples of activities that can be funded include:

device development, including proof-of-concept, prototyping, and piloting studies

manufacturing samples for product trials

clinical assessment

locating other national and international trials and research relevant to the product under development

business planning, including conducting market and product assessments

intellectual property management

commercialisation

capital raising

Key Dates:
Preliminary applications close: 9 June 2026, 5:00pm AEST
Full applications for this grant are by invitation only.
Notification of final outcomes: February 2027
SEE GRANT GUIDELINESSEE WEBSITE

Brisbane Marathon Festival 2026
2026-06-07
The Brisbane Marathon Festival is an annual running event featuring a marathon, half marathon, 10 km, 5 km, and 2 km race, attracting thousands of participants. The feeling of crossing that finish line and achieving your goal is like no other, so take that first step and sign up now!
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

Rosebud Running Festival 2026
2026-06-07
The Rosebud Running Festival course will cover sections along the foreshore trails (Bay trial) with runners being able to enjoy running through some stunning landscapes with Port Phillip Bay as the backdrop. The course will take competitors from the Start/Finish line at Rosebud to McCrae and back to Rosebud for the 5km and 10km events. The Marathon (2 Laps) + Half Marathon competitors will continue past the start line at Rosebud and head towards Capel Sound with the turnaround just before the Rye Pier and finish at Rosebud. The weekend features a variety of running & walking events to suit all ages and fitness levels. All finishers receive a finishers medal.
When you nominate MIA as your charity of choice, funds raised support our life-saving melanoma research, so we can reach our mission of zero deaths from melanoma.
Make sure you set up your fundraising page, as well as registering for the event – both can be done at the link below.
REGISTER NOW

SNOW MEDICAL Snow Fellowship
2026-06-04 17:00
Snow Fellowships target emerging global research leaders that show the potential to drive, manage and influence the next generation of health and medical innovation. The Fellowship provides these emerging leaders the independence, funding and time to develop a bold research program, build their research team, and establish leadership experience.
Each Snow Fellowship will be valued at approximately $8 million over eight years for eligible early to mid-career researchers. Fellowship funding will be available to set up and operate a research laboratory, comprising salaries for the Snow Fellow and post doctoral researchers, PhD student scholarship top-ups, technical and laboratory management support, project funds and leadership development.
The Snow Fellowship program supports ambitious research and high-performing teams, and we believe that these are based on diversity, inclusivity and gender equality.
Snow Fellowship
Biomedical research
Up to $1M per year
8 years of funding (review at year 4/5)
Mentorship, leadership and management training support
Key Dates
Expression of Interest closes: 4 June 2026
Full Application opens (via invitation): 1st week of August 2026
Full Application closes: 1 October 2026
Interview: early February 2027
SEE GRANT GUIDELINESSEE WEBSITE

NHMRC Postgraduate Scholarships
2026-06-03 17:00
The National Health and Medical Research Council (NHMRC) Postgraduate Scholarships scheme funds successful applicants to attain a research based postgraduate degree – Doctor of Philosophy (PhD) or a Research Masters Degree.

It aims to support these outstanding health and medical graduates early in their career so they can be trained to conduct research that is internationally competitive and develop a capacity for original independent research within Australia.
The intended outcome of the Postgraduate Scholarships scheme is increased research capacity within Australia.
Postgraduate Scholarships may be funded by, or in conjunction with, other organisations. These grants offer opportunities to researchers whose work is particularly relevant to the priorities and research interests of the partner organisations.

Key Dates
Applications open: 8 April 2026
Minimum data due date: 13 May 2026
Applications close: 3 June 2026
Proposed peer review: July/August 2026
The Guidelines will be available here when the round opens.
SEE GRANT GUIDELINESSEE WEBSITE

Westmead Research Hub EMCR Symposium
2026-06-03 | Westmead Innovation Centre, Hawkesbury Rd, Sydney, NSW, 2145, Australia
The annual Westmead Research Hub EMCR Symposium brings together honest career journeys, practical tips & tricks, and high-quality oral presentations showcasing the incredible research from our EMCR community.
Hear from keynote speakers Professor Marc Wilkins and Professor Eddie Holmes who will share the real stories behind their career paths – what worked, what didn’t, and what they wish they’d known sooner. From navigating career transitions and building confidence to making the most of opportunities (and surviving setbacks), these sessions are all about practical advice you can actually use.
Alongside the career-focused talks, our programme features a series of short oral presentations and poster presentations highlighting innovative research from EMCRs across the research hub.
We will finish the day off with a panel discussion about “How to conduct impactful research” with A/Prof Emily Blyth, Prof Hilda Pickett, Prof Tony Weiss, and Professor Michael Griffiths.
Whether you’re figuring out your next step, polishing your presentation skills, or just keen to connect with fellow EMCRs who understand what you are going though, this symposium promises insight, encouragement, and plenty of take-home tips.
Location: Westmead Innovation Centre, Westmead, NSW
Key Date: 3 June 2026, 8:30 am – 5 pm AEST
Registration Closes: 22 May 2026
FIND OUT MORE

The Viertel Charitable Foundation Clinical Investigator Awards
2026-05-30 17:00
Establishment grants for Clinical Investigators have been initiated by the Foundation in order to stimulate and encourage clinical research in Australia. In particular the grants are intended to assist new investigators to establish their research programs at the time of the difficult transition from doctoral and post-doctoral training posts to their first definitive clinical positions in an academic environment. Clinical Investigators are awarded a once only grant of $90,000.
Eligible applicants will be medical graduates or graduates of other clinical disciplines who have completed both their clinical and research training which will normally be at doctoral level and are commencing their first definitive clinical position, or have been in such a post for no more than 36 months on 1 May of the year of application.
Applicants should be actively engaged in clinical work and pursuing health and medical research in a university clinical department, a teaching hospital, a clinical research unit of a research institute or in an academic general practice setting. The applications will be judged predominantly on the quality of the applicant’s track record and career achievements to date. The quality of a brief research proposal will also be taken into account.
Key Dates
Applications open: 6 April 2026
Applications close: 30 May 2026
The Guidelines will be available here when the round opens.
SEE GRANT GUIDELINESSEE WEBSITE

Perpetual Ramaciotti Health Investment Grants
2026-05-29 17:00
Ramaciotti Health Investment grants of up to $100,000 are awarded to individuals in universities, public hospitals or institutes for a contribution towards the undertaking of health or medical research with the potential path to clinical application within five years. A Health Investment grant is intended to provide enabling research support for an autonomous early career investigator who is taking, or has recently taken, a substantive position.
Grants are awarded by Perpetual, Trustee of the Foundations, on the recommendation of a dedicated Scientific Advisory Committee.
In 2026 The Ramaciotti NSW Foundation will award up to six grants and The Ramaciotti Australia Foundation up to four grants. The Ramaciotti Australia Foundation supports organisations outside of NSW.
Key Dates
Applications close: Friday 29 May 2026, 5pm AEST
Applicants advised of outcome: September 2026
Recipients announced: October 2026
SEE GRANT GUIDELINESSEE WEBSITE

Perpetual Ramaciotti Medal for Excellence in Biomedical Research
2026-05-29 17:00
The Ramaciotti Medal is an annual award of $50,000. The Medal honours an individual who has made an outstanding discovery (or discoveries) in clinical or experimental biomedical research that has had an important impact on biomedical science, clinical science, or the way in which healthcare is delivered.
To be eligible for the Ramaciotti Medal, the greater part of the nominee’s work leading to the discovery (or discoveries) must have been conducted in Australia and they must still be actively engaged in this work.
The applicant must be peer nominated and the final recipient is selected based on a recommendation by the Ramaciotti Foundations Scientific Advisory Committee to Perpetual. Many past winners are highly regarded individuals in the top echelon of the biomedical research industry.
Key Dates
Applications close: Friday 29 May 2026, 5pm AEST
Applicants advised of outcome: September 2026
Recipients announced: October 2026
SEE GRANT GUIDELINESSEE WEBSITE

2026 ASCO Annual Meeting
2026-05-29 - 2026-06-02 | McCormick Place Convention Center, Chicago, IL, 60616, United States
#ASCO26 is The Place to Be Inspired
The 2026 ASCO (American Society Of Clinical Oncology) Annual Meeting Program will feature over 200 sessions complementing Dr. Eric Small’s Presidential theme, The Science and Practice of Translation: Improving Cancer Outcomes Worldwide.
Your all-access pass to the most clinically relevant cancer science. #ASCO26 session highlights include:

Plenary Session, featuring the meeting’s most practice-changing and clinically relevant abstract presentations and discussions
Opening Session, featuring the Presidential Address and Karnofsky Award and Lecture
ASCO Voices
24 Oral Abstract Sessions, 24 Rapid Oral Abstract Sessions, and 13 Clinical Science Symposia, featuring over 450 oral abstract presentations
15 Case-Based Panels, featuring interactive audience polling
Joint Sessions with AACR, ASPO, and ECO
Over 2,700 Poster presentations, including Trials in Progress

Location: McCormick Place, Chicago & Online
Key Dates:
Abstract Submitter Opens: November 5 2025
Abstract Submission Deadline: January 27 2026, at 11:59 PM (ET)
Late-Breaking Abstract Submission Deadline: March 9 2026, at 12:00 PM (Noon) (ET)
Abstract Notification Sent to First Author: March 27 2026
Abstract Withdrawal Deadline: April 5 2026
Abstract Titles, including LBAs, Released online: April 21 2026
Regular Abstracts Released on ASCO.org/abstracts: May 21 2026 at 5:00 PM ET
FIND OUT MORE
